Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

  2021 2020 2019 2018 2017 2016

Year wise published articles

50 27 55 66 38 13

Year wise citations received

494 462 352 277 260 226
Journal total citations count 3847
Journal impact factor 12.24
Journal 5 years impact factor 8.50
Journal cite score 10.62
Journal h-index 29
Journal h-index since 2018 21
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Shen YC, Liang CY, Wang CY, Lin KH, Hsu MY et al. (2014) Pharmacokinetics and safety of intravitreal caspofungin. Antimicrobial agents and chemotherapy. 58(12):7234-7239.
    View at Publisher | View at Google Scholar
  • Abadi AT, Ghasemzadeh A, Taghvaei T, Mobarez AM (2012) Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Internal and emergency medicine 7: 447-452.

    View at Publisher | View at Google Scholar
  • Giles TD (2011) Aspects of some complex issues in hypertension. Therapy 8: 209-210.

    View at Publisher | View at Google Scholar
  • Davis SL, Vazquez JA (2007) Anidulafungin: an evidence-based review of its use in invasive fungal infections. Core evidence. 2(4):241.
    View at Publisher | View at Google Scholar
  • Gisbert JP, Calvet X, O'Connor JA, Mégraud F, O'Morain CA (2010) The sequential therapy regimen for Helicobacter pylori eradication. Expert opinion on pharmacotherapy 11: 905-918.

    View at Publisher | View at Google Scholar
  • Zullo A, Hassan C, Cristofari F, Iegri C, De Francesco V (2010) How to manage Helicobacter pylori after sequential therapy failure?. Journal of clinical gastroenterology 44: 459-460.

    View at Publisher | View at Google Scholar
  • Gisbert JP, Romano M, Molina-Infante J, Lucendo AJ, Medina E, et al. (2015) Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments. Digestive and Liver Disease 47: 108-113.

    View at Publisher | View at Google Scholar
  • Zullo A, Hassan C, Eramo A, Morini S (2006) Helicobacter pylori therapy: what is coming?. Expert Opinion on Therapeutic Patents 16: 1107-1112.

    View at Publisher | View at Google Scholar
  • Yaxley J, Chakravarty B (2014) 'Helicobacter pylori'eradication-an update on the latest therapies. Australian family physician 43: 301.

    View at Publisher | View at Google Scholar
  • Gisbert JP, Calvet X, Bermejo F, Boixeda D, Bory F,et al. (2013) III Conferencia Española de Consenso sobre la infección por Helicobacter pylori. Gastroenterol Hepatol 36: 340-374.

    View at Publisher | View at Google Scholar
  • Lim JH, Lee DH, Lee ST, Kim N, Park YS, et al. (2015) Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection. World journal of gastroenterology 21: 13124.

    View at Publisher | View at Google Scholar
  • Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, et al. (2011)  Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. The Lancet infectious diseases 11: 942-951.

    View at Publisher | View at Google Scholar
  • Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F,  et al. (2009) Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bulletin of the World Health Organization 87: 754-762.

    View at Publisher | View at Google Scholar
  • Bärnighausen T, Bloom DE (2009)  “Conditional scholarships” for HIV/AIDS health workers: educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa. Social science & medicine. 28: 544-551.

    View at Publisher | View at Google Scholar
  • Hontelez JA, Newell ML, Bland RM, Munnelly K, Lessells RJ, et al (2012) Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study. Human resources for health 10: 39.

    View at Publisher | View at Google Scholar
  • Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, et al. (2014) Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PloS one 9: e104178.

    View at Publisher | View at Google Scholar
  • Wallrauch C, Bärnighausen T, Heller T, Houlihan C, Newell ML (2008) The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa. Future 2: 437-451.

    View at Publisher | View at Google Scholar
  • Sikstrom L (2014) “Without the grandparents, life is difficult”: Social hierarchy and therapeutic trajectories for children living with HIV in rural Northern Malawi. Children and Youth Services Review 45: 47-54.

    View at Publisher | View at Google Scholar
  • Garcia ME, Li MS, Siril H, Hawkins C, Kaaya S, et al. (2011) Health-care worker engagement in HIV-related quality improvement in Dar es Salaam, Tanzania. International Journal for Quality in Health Care 23: 231-238.

    View at Publisher | View at Google Scholar
  • Bärnighausen T, Kyle M, Salomon JA, Waning B  (2012) Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health policy and planning 27: 467-76.

    View at Publisher | View at Google Scholar
  • Bärnighausen T (2008) Reasons for loss to follow-up in antiretroviral treatment programs in South Africa. Future 2: 141-145.

    View at Publisher | View at Google Scholar
  • Govender V, Fried J, Birch S, Chimbindi N, Cleary S (2015) Disability Grant: a precarious lifeline for HIV/AIDS patients in South Africa. BMC health services research 15: 227

    View at Publisher | View at Google Scholar
  • Bärnighausen T, Bloom DE, Humair S (2009) A mathematical model for estimating the number of health workers required for universal antiretroviral treatment. National Bureau of Economic Research .

    View at Publisher | View at Google Scholar
  • Bärnighausen T, Bloom D, Humair S (2008) Estimating health worker need to provide antiretroviral treatment in the developing world. Program on the Global Demography of Aging.

    View at Publisher | View at Google Scholar
  • Cooke GS (2007) Evolution of adult antiretroviral therapy for programmatic delivery in Africa and the potential role for new therapeutic approaches. Therapy 4: 767-774.

    View at Publisher | View at Google Scholar
  • Bärnighausen T, Bloom DE. PROGRAM ON THE GLOBAL DEMOGRAPHY OF AGING.

    View at Publisher | View at Google Scholar
  • Hirschhorn LR, Newell ML (2007) Challenges and opportunities for expanding HIV care and treatment: what can be. Therapy 4: 701-703.

    View at Publisher | View at Google Scholar
  • Giles TD (2011) Aspects of some complex issues in hypertension. Therapy 8: 209-210.

    View at Publisher | View at Google Scholar
  • Hage FG, Mansur SJ, Oparil S. Renin–angiotensin–aldosterone inhibitors in combination therapy.

    View at Publisher | View at Google Scholar
  • Talasaz AH, Khalili H, Jenab Y, Salarifar M, Broumand MA, et al. (2013) N-Acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction. Drugs in R&D 13: 199-205.

    View at Publisher | View at Google Scholar
  • Talasaz AH, Khalili H, Fahimi F, Jenab Y, Broumand MA, et al. (2014) Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial. American Journal of Cardiovascular Drugs 14: 51-61.

    View at Publisher | View at Google Scholar
  • Hirschhorn LR, Newell ML (2007) Challenges and opportunities for expanding HIV care and treatment: what can be. Therapy 4: 701-703.

    View at Publisher | View at Google Scholar
  • Giles TD (2011) Aspects of some complex issues in hypertension. Therapy 8: 209-210.

    View at Publisher | View at Google Scholar
  • Saio V, Syiem D and Sharma R, 2012. Effect of Potentilla fulgens on lipid peroxidation and antioxidant status in alloxan-induced diabetic mice. Journal of basic and clinical pharmacy, 3(2), p.249.

    View at Publisher | View at Google Scholar
  • Cyril DG, Landry KS, Franįois KYK, Abou B, Felix YH, et al. Evaluation of Nephroprotective Activity of Aqueous and Hydroethanolic Extracts of Trema guineensis Leaves (Ulmaceae) against Gentamicin-Induced Nephrotoxicity in Rats. View at Publisher | View at Google Scholar
  • Thomson ISI, 2012. Saeideh Momtaz and Mohammad Abdollahi. Asian Journal of Animal and Veterinary Advances, 7(1), pp.1-19.

    View at Publisher | View at Google Scholar
  • El-Amier YA, Al-Hadithy ON, Abdulhadi HL and Fayed EM, Journal of Natural Products and Resources.

    View at Publisher | View at Google Scholar
  • Malekirad AA, Mohajerann HR, Rahzani K, Fani A, Pirasteh S. Improvement of Oxidative Stress Biomarkers in Human Plasma Following Consumption of Mentha Pulegium Decoction; a Before and after Clinical Trial.
  • Thomson ISI, 2011. Ali Akbar Malekirad, Nasser Hosseini, Mansour Bayrami, Touraj Hashemi, Kobra Rahzani and Mohammad Abdollahi. Asian Journal of Animal and Veterinary Advances, 6(9), pp.953-957.

    View at Publisher | View at Google Scholar
  • Al-Sawaf H, Mohamadin A, Sandukji A, Alrashidi Y and Sheweita SA, 2011. Oxidative stress and bone markers in plasma of patients with long-bone fixative surgery: role of antioxidants.

    View at Publisher | View at Google Scholar
  • Thomson ISI, 2010. P. Salari Sharif and M. Abdollahi. International Journal of Pharmacology, 6(5), pp.577-583.

    View at Publisher | View at Google Scholar
  • Mirzaei F, 2011. Muhammad Sarwar, Idress Hamad Attitalla and Mohammad Abdollahi. Asian Journal of Animal and Veterinary Advances, 6(8), pp.867-883.

    View at Publisher | View at Google Scholar
  • Thomson ISI, 2011. Pooneh Salari Sharif and Mohammad Abdollahi. International Journal of Pharmacology, 7(2), pp.180-188.

    View at Publisher | View at Google Scholar
  • Vitale E, 2011. Can Mango Reverse Bone Loss in Ovariectomized Mice? (Doctoral dissertation, Oklahoma State University).

    View at Publisher | View at Google Scholar
  • Rezvani N, 2011. Are Iron Chelators Safe to Be Used in Hyperoxia-induced Lung Injury?. International Journal of Pharmacology, 7(5), pp.546-547.

    View at Publisher | View at Google Scholar
  • Rahzani K, Malekirad AA, Zeraatpishe A, Hosseini N, Seify SMR, et al. Anti-oxidative stress activity of stachys lavandulifolia aqueous extract in human. Cell J. 2013; 14 (4): 314-317. Stachys lavandulifolia (S. lavandulifolia).

    View at Publisher | View at Google Scholar
  • Thomson ISI, 2011. Pooneh Salari and Mohammad Abdollahi. International Journal of Pharmacology, 7(5), pp.552-567.

    View at Publisher | View at Google Scholar
  • Warwick TJ, 2012. The effects of canola oil and coconut oil on bone quality in rats. Texas A&M University-Kingsville.

    View at Publisher | View at Google Scholar
  • Pang Z, Zhi-yan Z, Wang W, Ma Y, Feng-ju N, et al. The Advances in Research on the Pharmacological.

    View at Publisher | View at Google Scholar
  • Thomson ISI, 2010. Shirin Hasani-Ranjbar, Neda Nayebi, Bagher Larijani and Mohammad Abdollahi. International Journal of Pharmacology, 6(4), pp.315-325.

    View at Publisher | View at Google Scholar